Topic: Provigil

The hosts speculated that the prolific AI artist "Digital 2112 Man" is actually an alter ego of contributor Darren O'Neil, citing his love for the band Rush as a clue in the numeric code. The conversation shifted to a clarification regarding memory and alertness drugs, noting that "ProVigil" is a prescription medication used by fighter pilots to stay sharp, whereas "Prevagen" is a widely marketed supplement of questionable efficacy.

The hosts acknowledge high-level donors and executive producers, emphasizing the "value-for-value" funding model over traditional advertising. They discuss listener feedback on show segments and clarify the "180-day rule" regarding the government's ability to access "abandoned" emails on third-party servers.

A report from President Obama's physical exam mentions "physician-prescribed medication" for jet lag management, which the hosts suspect is Provigil (modafinil). An ABC News segment by Diane Sawyer is played, describing Provigil as a "secret" tool for successful Americans, including lobbyists and programmers. The hosts note that a common side effect of the drug is a skin rash, which they claim the President has exhibited.

The pharmaceutical industry is criticized for tactics like buying out generic competitors to keep prices high. Historical anecdotes are shared regarding "Doctor Feelgood" figures who allegedly provided methamphetamine shots to President John F. Kennedy. The discussion suggests that high-stress occupations, from the presidency to rock stars like Bon Jovi, often involve pharmaceutical enhancement.

The limitations of modern insurance networks are discussed, noting that many alternative or specialized doctors do not accept major plans like Blue Cross Blue Shield. The segment also critiques the pharmaceutical industry, specifically how companies buy out generic manufacturers to keep prices high, citing the drug ProVigil as an example.

The hosts critique a 60 Minutes segment that they characterize as a promotion for Adderall and Provigil. They note that Provigil's patent is set to expire in two years, suggesting the media coverage is a coordinated PR effort to maximize sales before the drug goes generic.